OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
PATK Patrick Industries Inc
ICD Independence Contract Drilling Inc
EAC Edify Acquisition Corp
ABNAF Aben Resources Ltd
PITPY Indocement Tunggal Prakarsa Tbk PT
OPEN Opendoor Technologies Inc
CNX CNX Resources Corp
BYOC Beyond Commerce Inc
NSP Insperity Inc

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.

Closing Price
Day's Change
0.54 (4.22%)
B/A Size
Day's High
Day's Low

10-day average volume:



6 providers
September 20, 2021
OraSure Receives $205 Million Procurement Contract for InteliSwab(TM) from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response

OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Defense Logistics Agency has awarded the Company a procurement contract for its...(Globe Newswire)

August 10, 2021
HIV Diagnostics Market Revenue to Cross USD 760 Mn by 2027: Global Market Insights Inc.

According to the latest report, "HIV Diagnostics Market by Test Type (Antibody Test, Viral Load Test, CD4 Test), End-use (Diagnostic Laboratories, Hospitals & Clinics, Home Settings), Regional Outlook, Price Trends, Competitive Market Share...(PR Newswire)

August 03, 2021
OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business

-- Excluding COVID-19 product revenues, revenues for the second quarter grew 122% YoY and 48% sequentially as the Company's core business began to return to pre-pandemic revenue levels -- Company received three Emergency Use Authorizations (EUAs)...(Globe Newswire)

July 29, 2021
Slone Partners Places Scott Gleason as Senior Vice President Investor Relations and Corporate Communications at OraSure Technologies

Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Scott Gleason as Senior Vice President Investor Relations and Corporate Communications at OraSure...(PR Newswire)

July 27, 2021
OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET

OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 second quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, August 3, 2021. (Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.